Jushi (OTCMKTS:JUSHF - Get Free Report) is expected to announce its earnings results after the market closes on Thursday, May 8th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $66.23 million for the quarter.
Jushi (OTCMKTS:JUSHF - Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.02). The firm had revenue of $65.86 million during the quarter, compared to the consensus estimate of $64.03 million. On average, analysts expect Jushi to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Jushi Stock Performance
Shares of JUSHF stock traded up $0.02 during midday trading on Tuesday, hitting $0.44. 315,594 shares of the company were exchanged, compared to its average volume of 234,073. The firm's 50 day moving average price is $0.30 and its two-hundred day moving average price is $0.33. The firm has a market capitalization of $85.85 million, a P/E ratio of -1.62 and a beta of -0.86. Jushi has a 52 week low of $0.22 and a 52 week high of $0.78.
About Jushi
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
See Also

Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.